ArticleCancers2023

Evaluation of Response to Atezolizumab Plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma Using the Combination of Response Evaluation Criteria in Solid Tumors and Alpha-Fetoprotein.

Takahiro Kinami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.